Sage Steele has called “fake news” on a report that claimed she was gunning to be the press secretary for the Trump ...

Shares of Sage Therapeutics (NASDAQ:SAGE) fell 18% post-market after the company released its Q3 earnings report and said ...

HMD Sage could get a 50-megapixel selfie shooter The handset is expected to come with a Unisoc T760 5G SoC The HMD Sage may support 33W wired charging ...

Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company specializing in central nervous system (CNS) disorders, finds itself at a critical juncture as it navigates the competitive ...

Sage Therapeutics, Inc. SAGE reported a loss of $1.53 per share for the third quarter of 2024, wider than the Zacks Consensus ...

Ofer’s Quantum Pacific acquired 767 Third Avenue in Midtown East for $88 million, the Commercial Observer reported. The ...

J.P. Morgan analyst Anupam Rama maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on November 6 and set a price target of $9.00. The company’s shares closed yesterday at $ ...

The Sage Group Plc engages in the provision of ... and North America. The company was founded by David Goldman, Paul Muller, and Graham Wylie in 1981 and is headquartered in Newcastle-upon-Tyne ...

Sage operates a patient support center on Brier Creek Parkway in Raleigh. According to its latest quarterly earnings report, the company has an operating lease for 15,525 square feet of space in ...

The discontinuation of SAGE-324, due to tolerability issues, has led the company to shift its focus to other early-stage assets. Among these is SAGE-319, an extra-synaptic preferential GABA PAM ...